Paushak Ltd. engages in the development and manufacturing of phosgene based specialty chemicals and intermediates. The company is headquartered in Vadodara, Gujarat and currently employs 311 full-time employees. The company went IPO on 2006-05-11. The company is engaged in the business of manufacturing phosgene-based specialty chemicals and intermediates. The company is also involved in manufacturing organic intermediates, such as Isocyanates, Chloroformates and Carbonyl Chlorides. The Company’s product Isocyanates include 2-Chloro Ethyl Isocyanate, 2-Phenyl Ethyl Isocyanate, 3-Chlorophenyl Isocyanate, 4-Chloro-3-(trifluoromethyl) Phenl Isocynate, P-Toluenesulfonyl Isocyanate, and Trans-4-Methyl Cyclohexyl Isocyanate. Its Chloroformates products include 2-Ethylhexyl Chloroformate, Allyl Chloroformate, Benzyle Chloroformate, Cetyl Chloroformate, and Ethyl Chloroformate. Its Carbonate/ Carbamate products include Polyquaternium, N-Butyl Propargyl Carbonate, and 3-Iodo 2 propynyl N-butyl Carbonate. Its Chlorides products include 3-Chloropropionyl Cloride, 4-Chloro Butyryl Cloride, and Diphenyl Carbamoyl Cloride. Its other products include Tetrabutyl Urea, Vilsmeier Reagent, and Fenofibric Acid.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.